Currently out of the existing stock ratings of David Low, 15 are a HOLD (40.54%), 19 are a BUY (51.35%), 3 are a SELL (8.11%).

David Low

Work Performance Price Targets & Ratings Chart

Analyst David Low, currently employed at JPMORGAN, has had 72.73% of price targets met with an average potential upside of 33.2%, reached in 239 days on average. Previously, David Low worked at OPPENHEIMER, MORGAN STANLEY.

David Low has documented 65 price targets and ratings displayed on 4 stocks. The coverage is on Healthcare, Consumer Cyclical, Industrials sectors.

Most recent stock forecast was given on RMD, ResMed at 15-Apr-2026.

Wall Street Analyst David Low

Analyst best performing recommendations are on NN (NEXTNAV ACQUISITION CORP).
The best stock recommendation documented was for RMD (RESMED) on 5/21/2021. The price target of $219 was fulfilled within 24 days with a profit of $26.12 (13.54%), with a performance score of 5.64.

Average potential price target upside

RMD ResMed AN AutoNation CSL Carlisle Companies NN Nextnav Acquisition Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 13-Oct-2025

$250

$10.47 (4.37%)

$215

17 days ago
(30-Oct-2026)

4/6 (66.67%)

$20.06 (8.72%)

40

Buy Since 06-Feb-2024

$277

$37.47 (15.64%)

$267

17 days ago
(30-Oct-2026)

7/16 (43.75%)

$47.06 (20.47%)

144

Buy Since 30-Oct-2026

$288

$48.47 (20.24%)

$262

17 days ago
(30-Oct-2026)

27/35 (77.14%)

$58.06 (25.25%)

279

Hold Since 30-Oct-2026

$270

$30.47 (12.72%)

$235

17 days ago
(30-Oct-2026)

9/15 (60%)

$40.06 (17.42%)

60

Hold Since 19-Aug-2026

$230

$8 (3.60%)

2 months 28 days ago
(19-Aug-2026)

1/1 (100%)

$0.01 (0.00%)

2

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by David Low?

On 2013
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?